[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsAntioxidant supplement,Antioxidant supplement, this study is a clinical trial study. Initially, capsules containing defined doses of antioxidant compounds are formulated with the formulation and based on related studies in a pharmaceutical laboratory located in Tehran province, a pharmacologist prepares, manufactures and quality controls. This capsule contains 250 mg of vitamin C, 300 mg of N-acetylcysteine, 2.5 mg of melatonin, 100 mg of selenium, 200 mg of glutathione and 60 mg of vitamin E and 5 mg of zinc. These supplements are purchased commercially from reputable companies active in this field in higher quantities by calculating the required amount according to their defined formulation and taking into account the number of patients, and the capsules are prepared, packaged and prepared in the pharmaceutical company. Target groups will receive two supplements / placebo on the first day and one every day for 10 days in the coming days. First, the informed consent form will be delivered to all patients and written consent will be obtained from them.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsPlacebo,Placebo, this group of patients with Covid 19 (Non-Critical) who will receive routine drugs of the country's treatment protocol and will receive two placebo on the first day and one every day for 10 days in the coming days. Patients will be imaged before treatment begins.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 93, "treatment_name": "Antioxidant therapy", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]